Abstracts

We are excited to announce that the abstract submission for the 8th Theranostics World Congress (TWC2026) is now open!

We invite researchers, clinicians, and professionals in the field of theranostics and radiomolecular precision medicine to contribute to the scientific programme of one of the leading global congresses in the field.

Whether your work focuses on clinical applications, translational research, novel radiopharmaceuticals, imaging technologies, or health system innovation – we look forward to your submission and to showcasing the breadth and depth of our growing community.

Join us in shaping the future of theranostics – and take the stage in Cape Town, South Africa, from January 29 to February 1, 2026.

Submission deadline

September 26, 2025 (23:59 CET)

Publication

All accepted abstracts will be published in an abstract book and online on the congress website.

Important Information Regarding Abstract Submission

  1. Please read through the Guidelines for Preparation and Rules for Submission before preparing your abstract.
  2. Abstract submission is open from May 2025 and is only possible via the abstract submission portal. Unfortunately, we cannot accept abstracts submitted by email.
  3. If the abstract is accepted, presenters must register for the congress and pay the registration fee.

Submit Your Abstract

Not sure how to submit your abstract?
This short video explains the entire submission process – from logging in, entering your abstract information, to uploading your files and finalizing your submission.

Ready to contribute to TWC2026?
Click the button below to access the abstract submission portal and share your research with the global theranostics community.

Abstract Topics

Abstracts can be submitted for one of the following topics:

  • Solid tumours including NET
  • Prostate Cancer
  • Medical Physics & Instrumentation
  • Antibody drug conjugates and diversification of the mechanisms of action
  • Novel Targets & Chemistry
  • Novel Indication, Concepts & Genetics
  • TME Diagnosis
  • TME Therapy
  • Radioisotope Production outlook
  • Basic and Translational Research & Radiobiology
  • Combination Therapies

Guidelines for preparation

Before you begin, please prepare the following information:

Select the abstract topic from the list of topics.

The abstract title should be short, informative and contain the major key words.

Limited to 2500 characters (without spaces).

Abstracts are to be structured in the following specified subtitles: aim, material & methods, results, conclusion.

Contact details of the main author, the co-authors and the presenting author: name, email address, affiliation details

Please list all authors and their affiliations as part of the abstract submission. The main author must be listed first.

Abstract Submitters will be required to disclose any conflict of interests in the submission form.

Please don’t use commercial drug names, brands or trademarks. Please remove company names, websites and mail addresses from the abstract.

The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline, if not submitted, drafts will be deleted.

Click on the SUBMIT button at the end of the process in order to submit your abstract.  Please do not submit multiple copies of the same abstract. Even if the abstract has already been submitted, changes can be made to it until the abstract submission deadline.

You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract. Please contact us if you have not received confirmation that your abstract has been submitted.

Rules for Submission

Please read the submission rules before submitting an abstract.

Abstracts are to be submitted and presented in English.

Abstracts must be received by the announced deadline, September 26, 2025 (23:59 CET). Abstracts received after the deadline will not be considered.

All submissions must be completed electronically via the online abstract submission portal.

The Organizing Committee reserves the right to decide whether a submission will be accepted, and the right to determine the presentation form. All accepted abstracts will be presented as posters. A limited number of abstracts will be selected for oral presentations.

The abstract submission constitutes a formal commitment by the author to present the abstract in the poster session and time slot assigned by the Scientific Committee.

The presenter will be required to register and pay for the Congress to ensure their abstract(s) are included in the final program and abstract book. If the presenter fails to register and pay, her/his abstract will be excluded from the scientific programme and publication.

Upon submission, both the submitter and the co-authors will receive an email containing all information about the abstract. The abstract text is also attached to this email. Authors are advised to proofread their abstracts because abstracts will be reproduced from the online submission. Any error in spelling, grammar or data will appear in the programme and the abstract book.

Notification of acceptance or rejection by the Scientific Committee will be emailed to the submitting author. Detailed information in which format the abstract is accepted (poster presentation or Best-of-Abstract) as well as guidelines and recommendations for each abstract type will be sent shortly after notifications to registered submitting authors.

Contact form

If you have any questions or need further information, please contact us:

Project Management
Stefanie Schmidt
Phone: +49 30 652126-446
E-Mail: stefanie.schmidt@kukm.de

Coordination Speakers & Abstracts & Participants
Klara Kiss
E-Mail: organization@theranostics-world-congress.org